Fits Health

Fit And Well, Daily

Breaking News
Body Checks

New Jersey startup AstraNu secures funding for compact medical imaging

By Fern Covington November 17, 2026
New Jersey startup AstraNu secures funding for compact medical imaging - compact medical imaging
Unlike traditional OCT systems, AstraNu’s design delivers comparable performance while occupying roughly one-tenth the space.

AstraNu, a New Jersey-based startup, has secured $3.5 million in seed funding to advance its optical coherence tomography (OCT) imaging engine. The round was led by Celesta Capital, with additional support from the New Jersey Innovation Evergreen Fund, a program under the New Jersey Economic Development Authority.

The company’s core technology is a miniaturized swept-source OCT imaging engine. Unlike traditional OCT systems, AstraNu’s design delivers comparable performance while occupying roughly one-tenth the space. This makes it viable for integration into handheld or portable medical devices.

According to AstraNu’s president and general manager, Kevin Blalock, the founders have been working on the technology for roughly 10 years. Blalock said, “We’re still very early stage, but the team has taken the technology and product from the prototype stage and just being able to demonstrate it to a point where we’re now partnering with manufacturers to test and decide how to proceed with the technology.” The funding will accelerate development, including scaling production and validating the engine’s performance with potential partners.

Read Also: Hundreds of Thousands Protest Czech Media Funding Plan

The company plans to expand its photonics team and prepare its supply chain for volume manufacturing. Blalock stated, “We’re bringing our supply chain up to scale and maturing not only our product but our suppliers, so that they can keep up with what we’re anticipating the demand will be.”

While the technology was initially demonstrated in middle-ear imaging, AstraNu’s first commercial focus will be ophthalmology. Other potential applications include urology, oncology, and ear, nose, and throat care. Blalock said, “We have broad applications, and we’re working with some specific partners right now, but we are focused on the medical industry. We’re not a pure medical device company, but we are working with those medical device companies to improve their technology or to create a new product within their portfolio.”

Blalock emphasized collaboration over competition: “Right now, it’s really about partnering with our potential customers. I prefer to call them partners right now because there’s going to be a lot of joint development work with the companies that are going to be using our technology, but we’re entering into those conversations, testing and development with them right now.” The goal is to begin selling modules in volume by the mid-to-end of next year.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 Fits Health. All rights reserved.